Furthermore, we tested the overall survival of patients with CHIP mutations versus that of patients without CHIP mutations for 7 different cancer types, namely breast cancer (BRCA), lung adenocarcinoma (LUAD), ovarian (OV) cancer, stomach adenocarcinoma (STAD), COAD, low-grade glioma (LGG), and liver hepatocellular carcinoma (LIHC). Here, STUB1 is linked to lung adenocarcinoma.